Xavier Mariette
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 10
- Systemic Lupus Erythematosus Research 8
- Hematology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Blood disorders and treatments 3
- Immunology top 5%
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 3
-
- Salivary Gland Disorders and Functions 11
-
- Systemic Sclerosis and Related Diseases 4
-
- Bone health and treatments 3
- Co-authors
- Marc IttahJérémie SellamF. LavieJ.E. GottenbergPhilippe RavaudCorinne Miceli‐RichardSophie PouplinPhilippe Goupille
- Cited by
- RheumatologyHematologyGenetics
- Journals
- Journal of Clinical Oncology (2 papers)The Journal of Immunology (1 paper)Gastroenterology (1 paper)
- Partner nations
- FranceSpainUnited Kingdom
In The Last Decade
Xavier Mariette
36 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Rheumatology 671
- Hematology 310
- Genetics 284
- Immunology 554
- Infectious Diseases 280
Countries citing papers authored by Xavier Mariette
This map shows the geographic impact of Xavier Mariette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Mariette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Mariette more than expected).
Fields of papers citing papers by Xavier Mariette
This network shows the impact of papers produced by Xavier Mariette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Mariette. The network helps show where Xavier Mariette may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xavier Mariette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 0 | |
| 8 | Long-Term Safety of Tofacitinib up to 9.5 Years: A Comprehensive Integrated Analysis of the RA Clinical Development Program | 2018 | 5 |
| 9 | 2018 | 3 | |
| 10 | 2017 | 11 | |
| 11 | 2015 | 1 | |
| 12 | 2011 | 314 | |
| 13 | Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registrybreakdown → | 2009 | 460 |
| 14 | 2009 | 65 | |
| 15 | 2006 | 10 | |
| 16 | 2006 | 150 | |
| 17 | 2006 | 58 | |
| 18 | 2005 | 34 | |
| 19 | 2004 | 1 | |
| 20 | 1997 | 16 |
About Xavier Mariette
Xavier Mariette is a scholar working on Rheumatology, Genetics and Hematology, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Salivary Gland Disorders and Functions (11 papers), Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), Systemic Sclerosis and Related Diseases (4 papers), Blood disorders and treatments (3 papers), Tuberculosis Research and Epidemiology (3 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Rheumatology (671 citations), Hematology (310 citations) and Genetics (284 citations). Xavier Mariette has collaborated with scholars based in France, Spain and United Kingdom. Frequent co-authors include Marc Ittah, Jérémie Sellam, F. Lavie, J.E. Gottenberg, Philippe Ravaud, Corinne Miceli‐Richard, Sophie Pouplin, Philippe Goupille, D Émilie and Dominique Salmon. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.